Acucela raises $162.4 million in Japanese IPO

Ophthalmic play Acucela Inc. (Tokyo:4589) raised $162.4 million through the sale of 9.2 million shares at $17.65 in an IPO on Monday. The price values Acucela -- which is headquartered in Seattle, Wash., but listed on Tokyo Stock Exchange's Mothers -- at $628.7 million. In December, Acucela said it planned to sell 9.2 million shares at $15-$18. Mitsubishi UFJ Morgan Stanley Securities is underwriter. Acucela's first day of trading on Mothers is slated for Feb. 13 (see BioCentury, Dec. 23, 2013). ...